American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations - 24/08/11
Doi : 10.1016/j.jaad.2004.02.012
Lowell A. Goldsmith, MD a, Jean L. Bolognia, MD b, Jeffrey P. Callen, MD c, Suephy C. Chen, MD d, Steven R. Feldman, MD, PhD e, Henry W. Lim, MD f, Anne W. Lucky, MD g, Barbara R. Reed, MD h, Elaine C. Siegfried, MD i, Diane M. Thiboutot, MD j, Ronald G. Wheeland, MD k
a Department of Dermatology, University of Rochester School of Medicine, Rochester, New York, New York, USA
b Department of Dermatology, Yale Medical School, New Haven, Connecticut, USA
c Division of Dermatology, University of Louisville, Louisville, Kentucky, USA
d Department of Dermatology, Emory University, Atlanta, Georgia, USA
e Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
f Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
g Pediatric Dermatology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA
h Health Sciences Center, University of Colorado, Denver, Colorado, USA
i Department of Dermatology, St Louis University School of Medicine, St Louis, Missouri, USA
j Division of Dermatology, M. S. Hershey Medical Center, Hershey, Pennsylvania, USA
k Laser and Skin Surgery Center of Santa Fe, Santa Fe, New Mexico, USA
Plan
 | The information contained in this Consensus Conference on the Safe and Optimal Use of Isotretinoin is provided for educational purposes only. The American Academy of Dermatology invited a panel of recognized experts to participate in the Consensus Conference, which was held in February 2002. The information contained herein has been carefully reviewed and represents the consensus opinions of those experts at the time this report was prepared. It is not intended to establish exclusive course(s) of treatment and is not intended to establish practice parameters, mandatory guidelines, or standards of care. |
© 2004
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 50 - N° 6
P. 900-906 - juin 2004 Retour au numéro
Article précédent
- Is Degos' disease a clinical and histological end point rather than a specific disease?
- Whitney A High, Jennifer Aranda, Samir B Patel, Clay J Cockerell, Melissa I Costner
- Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea
- Jonathan Wilkin, Mark Dahl, Michael Detmar, Lynn Drake, Matthew H Liang, Richard Odom, Frank Powell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?